Dr. Megan A Baumgart
Claim this profileStudies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
5 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage III
Stage IV
PD-L1 positive
Clinical Trials Megan A Baumgart is currently running
More about Megan A Baumgart
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Megan A Baumgart has experience with
- Carboplatin
- Nab-paclitaxel
- Paclitaxel
- Pembrolizumab
- Pemetrexed
Breakdown of trials Megan A Baumgart has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Megan A Baumgart specialize in?
Megan A Baumgart focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Megan A Baumgart currently recruiting for clinical trials?
Yes, Megan A Baumgart is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Megan A Baumgart has studied deeply?
Yes, Megan A Baumgart has studied treatments such as Carboplatin, Nab-paclitaxel, Paclitaxel.
What is the best way to schedule an appointment with Megan A Baumgart?
Apply for one of the trials that Megan A Baumgart is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.